Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Allergic Rhinitis Drugs Market
Allergic Rhinitis Drugs Market Share
- Report ID: GMI5413
- Published Date: Jan 2023
- Report Format: PDF
Allergic Rhinitis Drugs Market Share
- Merck & Co.
- GlaxoSmithKline PLC
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim
- Unichem Laboratories
- Stallergenes Greer
- Sanofi S.A.
- Alcon (Novartis AG)
- Johnson & Johnson
- Meda AB
- Mylan NV
- Allergy Therapeutics PLC
- ALK-Abelló A/S
- Glenmark Pharmaceuticals Ltd
- Bayer AG
- Dr. Reddy’s Laboratories
- Adamis Pharmaceuticals
- Sun Pharmaceuticals
are key participants involved in the market. These firms focus on thorough R&D programs to expand their product portfolio and propel their market position.
Frequently Asked Questions (FAQ) :
Global market for allergic rhinitis drugs was valued at more than USD 12 billion in 2022 and is set to progress at over 2.5% CAGR over the next 10 years owing to technological advancements in the field of allergy diagnosis and treatment.
Online channel segment is foreseen to reach over USD 4 billion by the end of 2032 on account of the availability of swift service, beneficial discounts & offers from various manufacturers, and the strong preference of elderly patients.
Oral segment is poised to garner more than USD 6.5 billion in revenue by 2032 as a result of its high level of convenience, low cost, and non-invasive approach.
Allergic rhinitis drugs market in North America accounted for more than 37% of the revenue share in 2022 due to soaring technological developments in treatment methods and rising healthcare expenditures in the region.
Allergic Rhinitis Drugs Market Scope
×
Get a free sample of
Allergic Rhinitis Drugs Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below